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Molecular & Cellular Proteomics is pleased to announce
new guidelines and requirements for papers describing the
development and application of targeted mass spectrometry
measurements of peptides, modified peptides and proteins
(PDF). These guidelines will be implemented for papers sub-
mitted starting June, 2017.
Over the past several years, representatives from aca-
demia, clinical laboratories, and pharma, who are active de-
velopers and users of targeted mass spectrometry methods
and analysis tools for quantification of peptides and proteins
in complex biological or clinical samples, have worked to-
gether to develop a set of guidelines and requirements for
authors who want to publish targeted proteomics papers. Our
goals were to define what information authors must provide
regarding how such analyses were performed and the result-
ing data analyzed to ensure that reviewers and readers have
the ability to independently establish that the measurements
being reported using targeted MS methods are reliable—i.e.
that they specifically identify and quantify the analytes tar-
geted in a sample—and that the measurements are reproduc-
ible. The guidelines and requirements for authors that have
been developed grew out of an NCI-sponsored meeting and
subsequent publication describing a tiered, fit-for-purpose
approach to targeted assay development in mass spec-
trometry-based proteomics (1). We have also incorporated
numerous helpful and important suggestions from the com-
munity obtained during the 4-month-long public commen-
tary period.
The need for establishing guidelines for targeted MS meas-
urements parallels the situation in discovery proteomics prior
to 2004 when similar issues relating to lack of ability to as-
certain reliability of published results prompted the journal
Molecular & Cellular Proteomics to develop and adopt the first
set of guidelines for publication of peptide and protein iden-
tification data using mass spectrometry (2). These guidelines,
which have been repeatedly revised and updated over the
past several years (3–5), have been embraced in whole or in
part by other journals. The goal now, as it was then, is to try
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to ensure that reliable and reproducible high quality data
and results are entering the proteomics literature. We have
endeavored to avoid making these guidelines overly pre-
scriptive and intend to be flexible so as to allow for new
technologies and approaches that will inevitably arise. We
also intend to regularly revisit and revise the guidelines as
needed, as we have done for our other documents for
author guidance.
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